Thus, we can speculate that MOR activation as the result of endogenous or exogenous opioids can trigger the release of soluble factors (i.e., nerve growth factor) that promote neurogenesis within the pancreatic cancer microenvironment (22). This evidence concerns the gene OPRM1 and pancreatic neoplasm.